Biopsy of the lymph node was consistent with nodular sclerosing Hodgkin lymphoma. A PET scan identified mediastinal adenopathy and pulmonary lesions. A bronchoscopy was not initially performed to ...

Actor Dave Coulier, 65, has been diagnosed with stage 3 non-Hodgkin lymphoma. Coulier, formerly of “Full House,” revealed his diagnosis in an exclusive interview with People Wednesday.

Melissa Coulier Dave Coulier has been diagnosed with stage 3 non-Hodgkin lymphoma. The Full House actor, 65, tells PEOPLE exclusively he was diagnosed in October after an upper respiratory ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

Dave Coulier announced exclusively on the TODAY show that he's been diagnosed with Stage 3 non-Hodgkin lymphoma, a type of blood cancer that starts in the lymphatic system. The "Fuller House" star ...

Full House alum Dave Coulier says he has been diagnosed with stage 3 Non-Hodgkin lymphoma, a blood cancer that develops in the lymphatic system. The actor told People he was diagnosed in October ...

The "Full House" star, 65, said he was recently diagnosed with stage 3 Non-Hodgkin lymphoma, he shared in ... post that included a gallery of photos of them over the years. "My brother from ...

The star shared the first symptom that led to his Stage 3 cancer diagnosis, how he's coping and why he wants others to be ...

(My doctors) said, ‘Hey, we wish we had better news, but you have non-Hodgkin lymphoma, B-cell lymphoma.’ It was a shock.” ...

My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me. When a group of people told me my non-Hodgkin lymphoma cure was a miracle, I realized it was ...

"Five weeks ago, I was diagnosed with stage three, Non-Hodgkin Lymphoma. And in that time I've had three surgeries," he told Hoda Kotb on the TODAY Show. Full House star Dave Coulier reveals he ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.